Daily Stock Opinions and Ratings

Latest Stock Buy or Sell? Make More Informed Decisions!

Today, Jim Cramer - Mad Money and Stockchase Insights commented about whether ATD.B-T, ZUH-T, RIT-T, GIS-N, FCX-N, DDD-N, CBRL-Q, NOK-N, PLUG-Q, ZBRA-Q, TTWO-Q, BIGC-Q, U-N, SPLK-Q, M-N, PANW-N, COST-Q, DRI-N, GIS-N, NKE-N are stocks to buy or sell.

Page 3/3

DON'T BUY

Their product is too expensive, making the stock unattractive.

DON'T BUY

A restaurant-with-gift shop franchise of 45 stores across the US. It thrives when people travel, and people aren't travelling now.

SELL

A dog. It's plunged from $70 to $5 and you'll be lucky to make a dollar or two.

BUY

FCX a copper and gold miner that's been lost for the past decade. Since May, the chart has Seen a solid rise. FCX's tailwind is China which is buying its minerals. FCX is up 29% YTD. Also, there are few publicly traded copper companies, so it's another tailwind. It's been a dog for so long, that investors have ignored FCX. Because interest rates are so low, their debt isn't as much as a problem now. FCX is a safer bet than the megacap cap tech stocks.

BUY

Reports Wednesday morning. A household name, but defensives have been tough to own lately. Investors find tech names sexy, but defensives. Pays a 3.4% yield and is growing faster than other consumer packaged goods names.

COMMENT

Billy Kawasaki’s Insights - Picks from 5i Research. The announcement from the Federal Reserve stating that interest rates are to stay low for a while will likely be positive for gold and stocks. Q2 results were pretty good and it should remain strong when the world reopens. The "anything is better than cash" mentality from low interest rates is likely to stay for a while. Unlock Premium - Try 5i Free

TOP PICK

Billy Kawasaki’s Insights - Picks from 5i Research. It has high quality assets and a strong return history. Although the fund charges higher fees, it is justified considering the good performance record and healthy distribution history. Unlock Premium - Try 5i Free

BUY

Billy Kawasaki’s Insights - Picks from 5i Research. Healthcare is likely to be a strong performer in the next five years. Subsectors like medical devices, telemedicine and therapeutics should lead. A good ETF for US exposure. Unlock Premium - Try 5i Free

BUY

Billy Kawasaki’s Insights - Picks from 5i Research. The company has potential to continue to grow at a good rate through acquisitions. Q2 results were satisfactory for investors and their balance sheet remains strong. Unlock Premium - Try 5i Free

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Stockchase Insights

5i Research

Jim Cramer - Mad Money

CNBC

Chris Heakes

Harvest Portfolios

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Latest Stock Buy or Sell? Make More Informed Decisions!

Nokia(NOK-N)

CBRL Group Inc.(CBRL-Q)

3D Systems(DDD-N)

Freeport McMoran Copper & Gold(FCX-N)

General Mills(GIS-N)

Billy Kawasaki’s Insights - Picks from 5i Research. (A Commentary)

CI First Asset Canadian REIT ETF(RIT-T)

BMO EqWt US HthCare Hedged CAD(ZUH-T)

Alimentation Couche-Tard (B)(ATD.B-T)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals